Literature DB >> 29994973

The many menopauses: searching the cognitive research literature for menopause types.

Hannaford Edwards1, Annie Duchesne2, April S Au1, Gillian Einstein1.   

Abstract

OBJECTIVE: Recent evidence suggests that early or induced menopause increases the risk for cognitive impairment and dementia. Given the potential for different cognitive outcomes due to menopause types, it is important that present research on menopause and cognition distinguishes between types. The aim of this project was to determine to what extent research looking at cognition in postmenopausal women published in one year, 2016, accounted for menopausal type.
METHODS: We searched MEDLINE, EMBASE, and PsychINFO using keywords and MeSH terms for menopause and cognition. We included any research paper reporting a cognitive outcome measure in a menopausal human population. Differentiation between the types of menopause was defined by four categories: undifferentiated, demographic differentiation (menopause type reported but not analyzed), partial differentiation (some but not all types analyzed), and full differentiation (menopause types factored into analysis, or recruitment of only one type).
RESULTS: Fifty research articles were found and analyzed. Differentiation was distributed as follows: undifferentiated, 38% (19 articles); demographic differentiation, 16% (8); partial differentiation, 28% (14); and full differentiation, 18% (9).
CONCLUSIONS: This review revealed that although some clinical studies differentiated between the many menopauses, most did not. This may limit their relevance to clinical practice. We found that when menopause types are distinguished, the differing cognitive outcomes of each type are clarified, yielding the strongest evidence, which in turn will be able to inform best clinical practice for treating all women.

Entities:  

Mesh:

Year:  2019        PMID: 29994973      PMCID: PMC6314513          DOI: 10.1097/GME.0000000000001171

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  98 in total

1.  Change in the ovarian environment after hysterectomy as assessed by ovarian arterial blood flow indices and serum anti-Müllerian hormone levels.

Authors:  Dong-Yun Lee; Hyun-Jung Park; Byoung-Gie Kim; Duk-Soo Bae; Byung-Koo Yoon; Dooseok Choi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-03-07       Impact factor: 2.435

2.  Impact of a premature menopause on cognitive function in later life.

Authors:  J Ryan; J Scali; I Carrière; H Amieva; O Rouaud; C Berr; K Ritchie; M-L Ancelin
Journal:  BJOG       Date:  2014-05-07       Impact factor: 6.531

3.  Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.

Authors:  Riley Bove; Elizabeth Secor; Lori B Chibnik; Lisa L Barnes; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

Review 4.  Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Authors:  Philip M Sarrel; Shannon D Sullivan; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-10-25       Impact factor: 7.329

Review 5.  Physiologic aspects of natural and surgical menopause.

Authors:  G Bachmann
Journal:  J Reprod Med       Date:  2001-03       Impact factor: 0.142

6.  Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties.

Authors:  Sheila Shanmugan; James Loughead; Ravi Prakash Reddy Nanga; Mark Elliott; Hari Hariharan; Dina Appleby; Deborah Kim; Kosha Ruparel; Ravinder Reddy; Thomas E Brown; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

Review 7.  Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition.

Authors:  Alessandra Graziottin; Sandra R Leiblum
Journal:  J Sex Med       Date:  2005-09       Impact factor: 3.802

8.  Life course exposure to smoke and early menopause and menopausal transition.

Authors:  Hebatullah Tawfik; Jennie Kline; Judith Jacobson; Parisa Tehranifar; Angeline Protacio; Julie D Flom; Piera Cirillo; Barbara A Cohn; Mary Beth Terry
Journal:  Menopause       Date:  2015-10       Impact factor: 2.953

9.  Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative.

Authors:  Aladdin H Shadyab; Caroline A Macera; Richard A Shaffer; Sonia Jain; Linda C Gallo; Margery L S Gass; Molly E Waring; Marcia L Stefanick; Andrea Z LaCroix
Journal:  Menopause       Date:  2017-01       Impact factor: 2.953

10.  Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups.

Authors:  Mark A Espeland; Stephen R Rapp; JoAnn E Manson; Joseph S Goveas; Sally A Shumaker; Kathleen M Hayden; Julie C Weitlauf; Sarah A Gaussoin; Laura D Baker; Claudia B Padula; Lifang Hou; Susan M Resnick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-06-01       Impact factor: 6.053

View more
  5 in total

1.  Nutritional Risk Factors Associated with Vasomotor Symptoms in Women Aged 40-65 Years.

Authors:  Alexandra Tijerina; Yamile Barrera; Elizabeth Solis-Pérez; Rogelio Salas; José L Jasso; Verónica López; Erik Ramírez; Rosario Pastor; Josep A Tur; Cristina Bouzas
Journal:  Nutrients       Date:  2022-06-22       Impact factor: 6.706

Review 2.  Menopause, hormone therapy and cognition: maximizing translation from preclinical research.

Authors:  H A Bimonte-Nelson; V E Bernaud; S V Koebele
Journal:  Climacteric       Date:  2021-05-12       Impact factor: 3.024

Review 3.  Psychosomatic and vasomotor symptom changes during transition to menopause.

Authors:  Areti Augoulea; Michalis Moros; Aikaterini Lykeridou; George Kaparos; Rallou Lyberi; Konstantinos Panoulis
Journal:  Prz Menopauzalny       Date:  2019-06-28

Review 4.  A Lifecourse Perspective on Female Sex-Specific Risk Factors for Later Life Cognition.

Authors:  Amalia Peterson; Sarah E Tom
Journal:  Curr Neurol Neurosci Rep       Date:  2021-07-06       Impact factor: 6.030

5.  Clinically Used Hormone Formulations Differentially Impact Memory, Anxiety-Like, and Depressive-Like Behaviors in a Rat Model of Transitional Menopause.

Authors:  Stephanie V Koebele; Ryoko Hiroi; Zachary M T Plumley; Ryan Melikian; Alesia V Prakapenka; Shruti Patel; Catherine Carson; Destiney Kirby; Sarah E Mennenga; Loretta P Mayer; Cheryl A Dyer; Heather A Bimonte-Nelson
Journal:  Front Behav Neurosci       Date:  2021-07-21       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.